Medical and Pharmaceutical Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’ Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment Rowan DunneMarch 11, 2026
AI and Autonomy Light AI develops smartphone tech for diagnosing severe throat infection The Vancouver-based medical equipment company completed its IPO earlier this month Rowan DunneJanuary 29, 2025